EW 123.57 Edwards Lifesciences Corp $EW Hit a 52 week high of 123.68 Closing the day 11/06/14 at 123.57 +2.47 +2.04% With a day low of 120.58 and a total volume of 793,842.
EW Recent Posts: http://investorshangout.com/Edwards-Lifescien...-EW-50936/
EW Edwards Lifesciences Corp Recent Headline News
Insider Trading Alert - EW, SLAB And LCI Traded By Insiders
at The Street - Thu Oct 30, 10:45AM CDT
Stocks with insider trader activity include EW, SLAB and LCI
LCI: 50.99 (-2.16), SLAB: 46.14 (-0.31), EW: 123.57 (+2.47)
Look for Shares of Edwards Lifesciences to Potentially Pullback after Yesterday's 1.45% Rise
Comtex SmarTrend(R) - Wed Oct 29, 4:26PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $118.01 to a high of $120.12. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $118.84 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 123.57 (+2.47)
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly
PR Newswire - Wed Oct 29, 7:35AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), AbbVie Inc. (NYSE: ABBV), Edwards Lifesciences Corp. (NYSE: EW) and Eli Lilly and Co. (NYSE: LLY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7520-100free.
GILD: 106.94 (+0.89), PFE: 30.04 (unch), EW: 123.57 (+2.47), LLY: 66.96 (-0.03), ABBV: 62.71 (+0.17)
IDEXX Tops Q3 Earnings and Revenues; Guidance Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:10PM CDT
Since the news release, IDEXX's (IDXX) share price has climbed 9.8% to eventually close at $138.76 yesterday.
ATEC: 1.45 (+0.04), EW: 123.57 (+2.47), IDXX: 145.91 (+1.80), ANGO: 16.85 (+0.10)
Morning Analysis on Health Care Equipment Stocks - Zimmer Holdings, Edwards Lifesciences, Varian Medical Systems, CareFusion, and Baxter Intl.
PR Newswire - Tue Oct 28, 7:35AM CDT
Investor-Edge has initiated coverage on the following equities: Zimmer Holdings Inc. (NYSE: ZMH), Edwards Lifesciences Corporation (NYSE: EW), Varian Medical Systems Inc. (NYSE: VAR), CareFusion Corporation (NYSE: CFN), and Baxter International Inc. (NYSE: BAX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, October 27, 2014, the NASDAQ Composite ended at 4,485.93, up 0.05%, the Dow Jones Industrial Average edged 0.07% higher to finish the day at 16,817.94, and the S&P 500 closed at 1,961.63, down 0.15%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 755.35, up 0.12%, with the index also advancing 5.54% in the previous three months. Register for your complimentary reports on these five stocks at:
ZMH: 110.19 (-0.80), VAR: 85.17 (+0.76), BAX: 71.60 (+0.70), CFN: 57.44 (+0.03), EW: 123.57 (+2.47)
Can the Rally in Edwards Lifesciences (EW) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 6:48AM CDT
Can the Rally in Edwards Lifesciences (EW) Shares Continue?
EW: 123.57 (+2.47)
Critical Alerts For petroleo brasileiro, SodaStream, Edwards Lifesciences, Micron and Starbucks Released By InvestorsObserver
PR Newswire - Mon Oct 27, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for PBR, SODA, EW, MU and SBUX.
SBUX: 77.45 (+0.79), MU: 33.35 (-0.36), PBR: 10.73 (-0.43), EW: 123.57 (+2.47), SODA: 22.46 (+0.57)
Edwards Lifesciences (EW) Worth Watching: Stock Up 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:25AM CDT
Edwards Lifesciences (EW) was a big mover last session, with shares rising 11% on the day.
BABY: 33.88 (-0.07), PACB: 6.53 (+0.19), EW: 123.57 (+2.47), ANGO: 16.85 (+0.10)
SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 11.00% Gain
Comtex SmarTrend(R) - Fri Oct 24, 3:53PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $113.22 to a high of $117.94. Yesterday, the shares gained 11.0%, which took the trading range above the 3-day high of $107.87 on volume of 2.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 123.57 (+2.47)
Stocks Hold Near Session Highs; Drugmakers Shine Again
at Investor's Business Daily - Fri Oct 24, 1:50PM CDT
Stocks looked poised to end the week on a positive note Friday. The Dow Jones industrial average added 0.6%; the S&P 500 rose 0.5% and the Nasdaq picked up 0.4%. NYSE was tracking lower than Thursday's level. Nasdaq volume was tracking close to...
AMZN: 296.64 (+0.12), SYNA: 63.54 (-2.31), EW: 123.57 (+2.47), SLXP: 138.55 (-0.95), MTX: 75.61 (+0.15), CELG: 107.14 (+1.99), GILD: 106.94 (+0.89), JAZZ: 172.37 (+5.19), ALXN: 193.14 (+3.25), PG: 88.90 (-0.10), CTCT: 34.58 (+0.08)
Edwards Lifesciences Hits New High On Q3 Earnings
at Investor's Business Daily - Fri Oct 24, 11:29AM CDT
Medical device maker Edwards Lifesciences (EW) jumped 11% to an all-time high in the stock market today after it beat Q3 earnings estimates late Thursday and got a barrage of price-target increases from analysts. Edwards' earnings rose 14% over the...
MDT: 68.74 (+0.04), EW: 123.57 (+2.47)
Edwards Lifesciences Tops Q3 Earnings, Revenues; Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 11:10AM CDT
Edwards' (EW) successful new product launches and pipeline updates strongly position the company to drive solid organic sales growth in the coming quarters.
ATEC: 1.45 (+0.04), PACB: 6.53 (+0.19), EW: 123.57 (+2.47), ANGO: 16.85 (+0.10)
Edwards Lifesciences (EW) Stock Is Up Double Digits Today After Raising Full Year Forecast
at The Street - Fri Oct 24, 10:54AM CDT
Edwards Lifesciences (EW) shares are climbing after the company beat analysts third quarter earnings expectations and raised its full year guidance.
EW: 123.57 (+2.47)
RTI Surgical (RTIX) Jumps: Stock Moves 12.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:46AM CDT
RTI Surgical (RTIX) was a big mover last session, with shares rising nearly 13% on the day.
ATEC: 1.45 (+0.04), RTIX: 5.07 (+0.07), EW: 123.57 (+2.47), ANGO: 16.85 (+0.10)
'Mad Money' Lightning Round: Covidien Is Done; Buy Edwards Lifesciences
at The Street - Fri Oct 24, 5:00AM CDT
Cramer didn't like what he saw in B&G Foods' quarter and doesn't want to be in CVR Partners.
BGS: 29.30 (+0.36), FB: 75.26 (+0.43), COV: 92.60 (-0.72), EW: 123.57 (+2.47), UAN: 11.60 (-0.37)
Jim Cramer's 'Mad Money' Recap: 10 Stocks That Led the Bulls' Charge
at The Street - Thu Oct 23, 7:07PM CDT
The bulls crushed the bears today in hand-to-hand combat, and Cramer gives 10 reasons why.
MMM: 156.05 (+0.36), JAH: 65.38 (+0.60), AVT: 43.66 (+0.06), FB: 75.26 (+0.43), ORLY: 179.61 (+2.15), COV: 92.60 (-0.72), EW: 123.57 (+2.47), BA: 124.58 (+0.36), UAN: 11.60 (-0.37), CELG: 107.14 (+1.99), TSCO: 74.40 (+1.04), DO: 36.65 (+1.22), NOW: 66.85 (+1.30), PH: 127.96 (+0.18), BGS: 29.30 (+0.36), AAL: 43.14 (+0.89), CAT: 100.91 (+1.50), FTK: 22.04 (+0.29), UNP: 118.94 (+2.53)
Edwards ups '14 EPS outlook
at Investor's Business Daily - Thu Oct 23, 6:01PM CDT
Edwards Lifesciences (EW) earnings rose 17.6% to 80 cents a share, topping by 8 cents, and sales grew 22.6% to $607.4 mil, beating views for $546.3 mil. The company raised its full-year EPS outlook to $3.33$3.39 vs. analyst views for $3.30, and it...
EW: 123.57 (+2.47)
Edwards Lifesciences beats Street 3Q forecasts
Automated Insights - Thu Oct 23, 3:39PM CDT
IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Thursday reported third-quarter earnings of $94.6 million.
EW: 123.57 (+2.47)
Edwards Lifesciences Reports Third Quarter Results
PR Newswire - Thu Oct 23, 3:01PM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended September 30, 2014 of $94.6 million, or $0.87 per diluted share, and non-GAAP net income of $87.0 million, or $0.80 per diluted share. Net income for the same period a year earlier was $76.8 million, or $0.68 per diluted share, and non-GAAP net income was $79.5 million, or $0.70 per diluted share.
EW: 123.57 (+2.47)
Varian Medical Systems Misses on Q4 Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:40PM CDT
Varian Medical Systems' (VAR) revenues in the quarter scaled up 5.5% to $812.1 million but lagged the Zacks Consensus Estimate of $838 million.
ATEC: 1.45 (+0.04), VAR: 85.17 (+0.76), EW: 123.57 (+2.47), ANGO: 16.85 (+0.10)
EW Recent Posts: http://investorshangout.com/Edwards-Lifescien...-EW-50936/
EW Edwards Lifesciences Corp Recent Headline News
Insider Trading Alert - EW, SLAB And LCI Traded By Insiders
at The Street - Thu Oct 30, 10:45AM CDT
Stocks with insider trader activity include EW, SLAB and LCI
LCI: 50.99 (-2.16), SLAB: 46.14 (-0.31), EW: 123.57 (+2.47)
Look for Shares of Edwards Lifesciences to Potentially Pullback after Yesterday's 1.45% Rise
Comtex SmarTrend(R) - Wed Oct 29, 4:26PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $118.01 to a high of $120.12. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $118.84 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 123.57 (+2.47)
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly
PR Newswire - Wed Oct 29, 7:35AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), AbbVie Inc. (NYSE: ABBV), Edwards Lifesciences Corp. (NYSE: EW) and Eli Lilly and Co. (NYSE: LLY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7520-100free.
GILD: 106.94 (+0.89), PFE: 30.04 (unch), EW: 123.57 (+2.47), LLY: 66.96 (-0.03), ABBV: 62.71 (+0.17)
IDEXX Tops Q3 Earnings and Revenues; Guidance Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:10PM CDT
Since the news release, IDEXX's (IDXX) share price has climbed 9.8% to eventually close at $138.76 yesterday.
ATEC: 1.45 (+0.04), EW: 123.57 (+2.47), IDXX: 145.91 (+1.80), ANGO: 16.85 (+0.10)
Morning Analysis on Health Care Equipment Stocks - Zimmer Holdings, Edwards Lifesciences, Varian Medical Systems, CareFusion, and Baxter Intl.
PR Newswire - Tue Oct 28, 7:35AM CDT
Investor-Edge has initiated coverage on the following equities: Zimmer Holdings Inc. (NYSE: ZMH), Edwards Lifesciences Corporation (NYSE: EW), Varian Medical Systems Inc. (NYSE: VAR), CareFusion Corporation (NYSE: CFN), and Baxter International Inc. (NYSE: BAX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, October 27, 2014, the NASDAQ Composite ended at 4,485.93, up 0.05%, the Dow Jones Industrial Average edged 0.07% higher to finish the day at 16,817.94, and the S&P 500 closed at 1,961.63, down 0.15%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 755.35, up 0.12%, with the index also advancing 5.54% in the previous three months. Register for your complimentary reports on these five stocks at:
ZMH: 110.19 (-0.80), VAR: 85.17 (+0.76), BAX: 71.60 (+0.70), CFN: 57.44 (+0.03), EW: 123.57 (+2.47)
Can the Rally in Edwards Lifesciences (EW) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 6:48AM CDT
Can the Rally in Edwards Lifesciences (EW) Shares Continue?
EW: 123.57 (+2.47)
Critical Alerts For petroleo brasileiro, SodaStream, Edwards Lifesciences, Micron and Starbucks Released By InvestorsObserver
PR Newswire - Mon Oct 27, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for PBR, SODA, EW, MU and SBUX.
SBUX: 77.45 (+0.79), MU: 33.35 (-0.36), PBR: 10.73 (-0.43), EW: 123.57 (+2.47), SODA: 22.46 (+0.57)
Edwards Lifesciences (EW) Worth Watching: Stock Up 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:25AM CDT
Edwards Lifesciences (EW) was a big mover last session, with shares rising 11% on the day.
BABY: 33.88 (-0.07), PACB: 6.53 (+0.19), EW: 123.57 (+2.47), ANGO: 16.85 (+0.10)
SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 11.00% Gain
Comtex SmarTrend(R) - Fri Oct 24, 3:53PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $113.22 to a high of $117.94. Yesterday, the shares gained 11.0%, which took the trading range above the 3-day high of $107.87 on volume of 2.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 123.57 (+2.47)
Stocks Hold Near Session Highs; Drugmakers Shine Again
at Investor's Business Daily - Fri Oct 24, 1:50PM CDT
Stocks looked poised to end the week on a positive note Friday. The Dow Jones industrial average added 0.6%; the S&P 500 rose 0.5% and the Nasdaq picked up 0.4%. NYSE was tracking lower than Thursday's level. Nasdaq volume was tracking close to...
AMZN: 296.64 (+0.12), SYNA: 63.54 (-2.31), EW: 123.57 (+2.47), SLXP: 138.55 (-0.95), MTX: 75.61 (+0.15), CELG: 107.14 (+1.99), GILD: 106.94 (+0.89), JAZZ: 172.37 (+5.19), ALXN: 193.14 (+3.25), PG: 88.90 (-0.10), CTCT: 34.58 (+0.08)
Edwards Lifesciences Hits New High On Q3 Earnings
at Investor's Business Daily - Fri Oct 24, 11:29AM CDT
Medical device maker Edwards Lifesciences (EW) jumped 11% to an all-time high in the stock market today after it beat Q3 earnings estimates late Thursday and got a barrage of price-target increases from analysts. Edwards' earnings rose 14% over the...
MDT: 68.74 (+0.04), EW: 123.57 (+2.47)
Edwards Lifesciences Tops Q3 Earnings, Revenues; Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 11:10AM CDT
Edwards' (EW) successful new product launches and pipeline updates strongly position the company to drive solid organic sales growth in the coming quarters.
ATEC: 1.45 (+0.04), PACB: 6.53 (+0.19), EW: 123.57 (+2.47), ANGO: 16.85 (+0.10)
Edwards Lifesciences (EW) Stock Is Up Double Digits Today After Raising Full Year Forecast
at The Street - Fri Oct 24, 10:54AM CDT
Edwards Lifesciences (EW) shares are climbing after the company beat analysts third quarter earnings expectations and raised its full year guidance.
EW: 123.57 (+2.47)
RTI Surgical (RTIX) Jumps: Stock Moves 12.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:46AM CDT
RTI Surgical (RTIX) was a big mover last session, with shares rising nearly 13% on the day.
ATEC: 1.45 (+0.04), RTIX: 5.07 (+0.07), EW: 123.57 (+2.47), ANGO: 16.85 (+0.10)
'Mad Money' Lightning Round: Covidien Is Done; Buy Edwards Lifesciences
at The Street - Fri Oct 24, 5:00AM CDT
Cramer didn't like what he saw in B&G Foods' quarter and doesn't want to be in CVR Partners.
BGS: 29.30 (+0.36), FB: 75.26 (+0.43), COV: 92.60 (-0.72), EW: 123.57 (+2.47), UAN: 11.60 (-0.37)
Jim Cramer's 'Mad Money' Recap: 10 Stocks That Led the Bulls' Charge
at The Street - Thu Oct 23, 7:07PM CDT
The bulls crushed the bears today in hand-to-hand combat, and Cramer gives 10 reasons why.
MMM: 156.05 (+0.36), JAH: 65.38 (+0.60), AVT: 43.66 (+0.06), FB: 75.26 (+0.43), ORLY: 179.61 (+2.15), COV: 92.60 (-0.72), EW: 123.57 (+2.47), BA: 124.58 (+0.36), UAN: 11.60 (-0.37), CELG: 107.14 (+1.99), TSCO: 74.40 (+1.04), DO: 36.65 (+1.22), NOW: 66.85 (+1.30), PH: 127.96 (+0.18), BGS: 29.30 (+0.36), AAL: 43.14 (+0.89), CAT: 100.91 (+1.50), FTK: 22.04 (+0.29), UNP: 118.94 (+2.53)
Edwards ups '14 EPS outlook
at Investor's Business Daily - Thu Oct 23, 6:01PM CDT
Edwards Lifesciences (EW) earnings rose 17.6% to 80 cents a share, topping by 8 cents, and sales grew 22.6% to $607.4 mil, beating views for $546.3 mil. The company raised its full-year EPS outlook to $3.33$3.39 vs. analyst views for $3.30, and it...
EW: 123.57 (+2.47)
Edwards Lifesciences beats Street 3Q forecasts
Automated Insights - Thu Oct 23, 3:39PM CDT
IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Thursday reported third-quarter earnings of $94.6 million.
EW: 123.57 (+2.47)
Edwards Lifesciences Reports Third Quarter Results
PR Newswire - Thu Oct 23, 3:01PM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended September 30, 2014 of $94.6 million, or $0.87 per diluted share, and non-GAAP net income of $87.0 million, or $0.80 per diluted share. Net income for the same period a year earlier was $76.8 million, or $0.68 per diluted share, and non-GAAP net income was $79.5 million, or $0.70 per diluted share.
EW: 123.57 (+2.47)
Varian Medical Systems Misses on Q4 Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:40PM CDT
Varian Medical Systems' (VAR) revenues in the quarter scaled up 5.5% to $812.1 million but lagged the Zacks Consensus Estimate of $838 million.
ATEC: 1.45 (+0.04), VAR: 85.17 (+0.76), EW: 123.57 (+2.47), ANGO: 16.85 (+0.10)
